Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
135.50
-6.00 (-4.24%)
At close: Feb 11, 2026

TPEX:3218 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
638.39506.851,063703.02534.19616
Short-Term Investments
86.77115.22578.36576.62505.81461.75
Trading Asset Securities
1,2161,295----
Cash & Short-Term Investments
1,9421,9171,6411,2801,0401,078
Cash Growth
-6.24%16.85%28.23%23.04%-3.50%51.56%
Accounts Receivable
518.65565.57584.25581.82534.93377.13
Other Receivables
9.6211.92.173.3711.3133.8
Receivables
528.27577.47586.42585.18546.25410.92
Inventory
338.59289.73294.52227.62115.6562.62
Other Current Assets
63.9557.1958.0366.5477.2190.78
Total Current Assets
2,8722,8422,5802,1591,7791,642
Property, Plant & Equipment
2,8082,6732,3232,2061,7241,413
Long-Term Investments
105.92111.07----
Other Intangible Assets
22.2922.7922.9825.9126.5726.52
Long-Term Deferred Tax Assets
71.5372.2667.2555.9148.3134.47
Other Long-Term Assets
59.4241.34137.0659.25171.7653.11
Total Assets
5,9395,7635,1314,5063,7503,169
Accounts Payable
245.26268.07312.31254.55210.5122.93
Accrued Expenses
193.64226.34226.54210.26170.08128.1
Short-Term Debt
229.1592.018.67--176.9
Current Portion of Long-Term Debt
--1.39.179.03-
Current Portion of Leases
184.64178.4155.27141.45130.72108
Current Income Taxes Payable
81.9154.45162.57134.3785.777.44
Current Unearned Revenue
44.625.1224.1923.3216.2414.22
Other Current Liabilities
190.6146.34132.25137.25109.39125.83
Total Current Liabilities
1,1701,0911,023910.38731.66753.41
Long-Term Debt
---1.3210.33-
Long-Term Leases
798.53783.83613.02631.7617.45329.24
Long-Term Deferred Tax Liabilities
57.3560.9358.3944.2624.94-
Other Long-Term Liabilities
46.1271.4993.1288.836.7847.04
Total Liabilities
2,0722,0071,7881,6761,4211,130
Common Stock
847.25847.25847.25799.29761.23761.23
Additional Paid-In Capital
381.92381.92381.92381.92381.92381.92
Retained Earnings
2,5012,3881,9601,4881,056779.86
Comprehensive Income & Other
-13.934.51-11.38-5.04-10.37-9.12
Total Common Equity
3,7173,6223,1782,6642,1881,914
Minority Interest
151.06133.72165.33165.02140.13125.55
Shareholders' Equity
3,8683,7563,3432,8292,3282,039
Total Liabilities & Equity
5,9395,7635,1314,5063,7503,169
Total Debt
1,2121,054778.26783.65767.53614.14
Net Cash (Debt)
729.2863.2862.65495.99272.47463.61
Net Cash Growth
5.25%0.07%73.92%82.03%-41.23%261.16%
Net Cash Per Share
8.5810.1610.165.853.215.46
Filing Date Shares Outstanding
84.7284.7384.7384.7284.7284.72
Total Common Shares Outstanding
84.7284.7384.7384.7284.7284.72
Working Capital
1,7031,7511,5571,2491,047888.66
Book Value Per Share
43.8742.7537.5131.4525.8322.59
Tangible Book Value
3,6943,5993,1552,6382,1621,887
Tangible Book Value Per Share
43.6042.4837.2331.1425.5222.28
Land
179.87179.87179.87179.87179.87179.87
Buildings
67.1167.1167.1166.7666.7666.65
Machinery
2,6492,4422,1651,8841,4801,346
Construction In Progress
177.0596.0132.8291.84--
Leasehold Improvements
694.35643.69615.67473.07340.85306.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.